VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 3 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2018. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $7,400,000 | +46.0% | 318,400 | 0.0% | 3.25% | +41.8% |
Q1 2018 | $5,069,000 | -1.0% | 318,400 | +29.2% | 2.29% | -12.6% |
Q4 2017 | $5,122,000 | +61.4% | 246,500 | +11.3% | 2.62% | +48.2% |
Q3 2017 | $3,174,000 | -2.7% | 221,500 | +17.5% | 1.77% | -14.2% |
Q2 2017 | $3,261,000 | +90.4% | 188,500 | +21.4% | 2.06% | +93.3% |
Q1 2017 | $1,713,000 | -24.0% | 155,300 | 0.0% | 1.07% | -31.0% |
Q4 2016 | $2,255,000 | -12.8% | 155,300 | +47.5% | 1.55% | -24.3% |
Q3 2016 | $2,585,000 | +122.1% | 105,300 | +82.2% | 2.04% | +74.2% |
Q2 2016 | $1,164,000 | -23.4% | 57,800 | 0.0% | 1.17% | -18.7% |
Q1 2016 | $1,520,000 | -61.6% | 57,800 | +48.6% | 1.44% | -62.1% |
Q4 2015 | $3,954,000 | – | 38,900 | – | 3.80% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |